Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Eom Pharmaceutical Holdings Inc (IMUC)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.198 +0.021    +12.16%
09:43:00 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 100
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.198 - 0.198
Eom Pharmaceutical Holdings 0.198 +0.021 +12.16%

IMUC Ratios

 
Assess the performance of Eom Pharmaceutical Holdings (IMUC). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Eom Pharmaceutical Holdings Inc's latest financial reports. Compare the performance metrics of Eom Pharmaceutical Holdings (IMUC) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM - 0.72
Price to Sales TTM - 716.27
Price to Cash Flow MRQ - 2.4
Price to Free Cash Flow TTM - -13.21
Price to Book MRQ - 4.31
Price to Tangible Book MRQ - 1.69
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM - -4,938.09
Gross Margin 5YA - -983.54
Operating margin TTM - -9,610
Operating margin 5YA - -2,917.21
Pretax margin TTM - -9,099.6
Pretax margin 5YA - -1,740.8
Net Profit margin TTM - -9,093.98
Net Profit margin 5YA - -4,772.71
   
Revenue/Share TTM - 38.23
Basic EPS ANN - 7.33
Diluted EPS ANN - 6.96
Book Value/Share MRQ - 63.04
Tangible Book Value/Share MRQ - 47.77
Cash/Share MRQ - 17.5
Cash Flow/Share TTM - 9.15
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM - -39.63
Return on Equity 5YA - -66.96
Return on Assets TTM - -13.87
Return on Assets 5YA - -11.93
Return on Investment TTM - -8.99
Return on Investment 5YA - -8.37
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 0% -20.73
EPS(TTM) vs TTM 1 Yr. Ago TTM 0% -71.86
5 Year EPS Growth 5YA - 6.03
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 0% 476.19
Sales (TTM) vs TTM 1 Yr. Ago TTM 0% 52.24
5 Year Sales Growth 5YA - 31.23
5 Year Capital Spending Growth 5YA - 20.56
   
Quick Ratio MRQ - 6
Current Ratio MRQ - 6.34
LT Debt to Equity MRQ - 39.81
Total Debt to Equity MRQ - 1.98
Efficiency    
Asset Turnover TTM - 0.32
Inventory Turnover TTM - 5.96
Revenue/Employee TTM - 608.57K
Net Income/Employee TTM - -401.07K
Receivable Turnover TTM - 6.7
   
Dividend Yield ANN - 0.03
Dividend Yield 5 Year Avg. 5YA - 0.03
Dividend Growth Rate ANN - 0.8
Payout Ratio TTM - 1.83
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IMUC Comments

Write your thoughts about Eom Pharmaceutical Holdings Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Deli Fare
Deli Fare Sep 30, 2022 4:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
soon 12.4 $
Deli Fare
Deli Fare Jun 06, 2018 3:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good News. Soon.
Bill Matt
Bill Matt Jun 06, 2018 3:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Would you like to embellish on that
Deli Fare
Deli Fare May 31, 2018 1:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Celgene buy Imuc
Deli Fare
Deli Fare Apr 17, 2018 9:07AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Strong Buy.
Shane Coburn
Shane Coburn Dec 21, 2017 10:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
A lot going on with this stock. class action lawsuit, prior CEO paid a company to promote or pump the stock. Turns out Immunocellular is asking the court for dismissal. We shall see... if dismissal. I'm all in, if the news is true and they have what they say they have then maybe to the moon with this one. Maybe, prior CEO didn't know what he was doing and the company was clueless, not many employees here. Also, what's going on with the clinical trials that are still on going, we know ICT-107 have been put on hold? However, No mention of Clinical Trial stage 1 ICT-121, more milestones over 18 months could this be the result of the recent new. Hush is the word here! $.29 is nothing for a stock if they play their cards right here.
dongmin ma
dongmin ma Dec 14, 2017 1:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should i but this ?
NicoReggae otr
NicoReggae otr Dec 14, 2017 1:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don’t buy penny stocks
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email